Skip main navigation
Skip sub navigation
Adjust font size: A   A   A

  E-Mail to a Friend

Members Only

Log in

Not registered?
Register now!

Science & Tech

Environmental Health & Safety 
07/31/07 AdvaMed's response to EPA's request for ethylene oxide (ETO) risk reduction measures
01/18/07 AdvaMed's statement to the EPA Science Advisory Board on the Evaluation of the Carcinogenicity of the Ethylene Oxide (EtO ) (pdf)
05/19/06 AdvaMed's Comments to the U.S. Environmental Protection Agency concerning agency's risk assessment for ethylene oxide (pdf)
03/23/05 U.S. Commercial Services' Briefing Paper: Requirements for Recycling Waster of Electronic and Electrical Equipment and Reduction of Hazardous Substances in the EU (pdf)

 

Critical Path

10/28/05 AdvaMed Comments on FDA Proposed Critical Path Workshop on Developing Prevention Therapies (pdf)
07/03/04 AdvaMed submits comments on FDA "Critical Path" (pdf)
04/22/04 AdvaMed presentation on FDA's "Critical Path" Initiative (pdf)

 

Patient Safety
06/16/05 AdvaMed's comments to the Institute of Medicine Committee on Identifying and Preventing Medication Errors (pdf)

Inside this section...

Combination Products
FDA Word on User Fees
Medical Device User Fee & Modernization Act
Why are Medical Technology User Fees Needed?
PDUFA: An Enormous Success for Patients